首页> 美国卫生研究院文献>British Journal of Cancer >Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.
【2h】

Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.

机译:通过阈值和光分级研究在正常大鼠结肠中增强了5-氨基乙酰丙酸诱导的卟啉光敏化的光动力疗法。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

5-Aminolaevulinic acid (ALA)-induced prophyrin photosensitisation is an attractive option for photodynamic therapy (PDT) since skin photosensitivity is limited to 1-2 days. However, early clinical results on colon tumours using the maximum tolerated oral dose of 60 mg kg-1 showed only superficial necrosis, presumably owing to insufficient intratumoral porphyrin levels, although inadequate light dosimetry may also be a factor. We undertook experiments using ALA, 25-400 mg kg-1 intravenously, to establish the threshold doses required for a PDT effect. Laser light at 630 nm (100 mW, 10-200 J) was delivered to a single site in the colon of photosensitised normal Wistar rats at laparotomy. The animals were killed 3 days later and the area of PDT-induced necrosis measured. No lesion was seen with 25 mg kg-1. The lesion size increased with larger ALA doses and with the light dose but little benefit was seen from increasing the ALA dose above 200 mg kg-1 or the light dose above 100 J. Thus there is a fairly narrow window for optimum doses of drug and light. Further experiments showed that the PDT effect can be markedly enhanced by fractionating the light dose. A series of animals was sensitized with 200 mg kg-1 ALA and then treated with 25 J. With continuous irradiation, the lesion area was 13 mm2, but with a single interruption of 150 s the area rose to 94 mm2 with the same total energy. Results were basically similar for different intervals between fractions (10-900 s) and different numbers of fractions (2-25). This suggests that a single short interruption in the light irradiation may dramatically reduce the net light dose required to achieve extensive necrosis.
机译:5-氨基戊酸(ALA)诱导的卟啉光敏化是光动力疗法(PDT)的一种有吸引力的选择,因为皮肤光敏性限于1-2天。然而,使用最大耐受口服剂量60 mg kg-1对结肠肿瘤的早期临床结果显示仅是表面坏死,这可能是由于肿瘤内卟啉水平不足,尽管光剂量不足也可能是一个因素。我们进行了使用25-400 mg kg-1静脉注射ALA的实验,以确定达到PDT效果所需的阈值剂量。在剖腹手术中,将630 nm(100 mW,10-200 J)的激光传递到光敏正常Wistar大鼠结肠的单个部位。 3天后杀死动物,并测量PDT诱导的坏死面积。 25 mg kg-1未见病变。随着ALA剂量的增加和光剂量的增加,病灶的大小增加,但是将ALA剂量增加至200 mg kg-1以上或将光剂量增加至100 J以上几乎没有好处。因此,最佳剂量的药物和光。进一步的实验表明,通过分光剂量可以显着增强PDT的效果。一系列动物用200 mg kg-1 ALA致敏,然后用25 J照射。在连续照射下,病变面积为13 mm2,但在150 s的单次中断下,面积增加到94 mm2,总能量相同。分数之间的不同间隔(10-900 s)和分数数量不同(2-25)的结果基本相似。这表明光照射的短时间中断可能会显着降低实现广泛坏死所需的净光剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号